emotive, a healthcare communications agency, has added new members to its client services team, it is reported today.
The company has named Andy Parry as its new senior account director. He has nine years of experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.
The firm has appointed Fay Lepley as account executive. She has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.
It has also appointed Oliver Morrissey as its senior account executive following his PR and healthcare communications experience in immuno-oncology, CVD and medical devices.
Sabrina Mohamed has been appointed as account executive after working in healthcare PR, specifically on measurement and social listening in various therapy areas including diabetes and CNS.
Merck announces Phase 3 trials for once-monthly oral HIV prevention pill MK-8527
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
Estrella Immunopharma initiates second cohort in EB103 trial for advanced B-cell lymphomas
bioMérieux receives CE-marking for LUMED APSS to support antimicrobial stewardship in Europe
Merck reports positive Phase 3 Data on HIV treatment DOR/ISL
QOL Medical's Sucraid shows 81% effectiveness in Congenital Sucrase-Isomaltase Deficiency
Qlucore launches first CE-marked diagnostic test for paediatric leukaemia
Bruker demonstrates advancements in 4D-Proteomics at US HUPO
Mitem Pharma acquires Flisint rights from Sanofi to address rare infectious disease
Audientes partners with Audivista to expand hearing solutions in Middle East and North Africa
Benuvia Operations signs licensing deal with Avernus Pharma
Benuvia Operations signs licensing and supply agreements with Medra Brasil Medicamentos
Castle Biosciences to present data on Melanoma tests at ASDP Annual Meeting
Alchemy partners with PatchRx to improve HIV medication adherence